© 2020 MJH Life Sciences and Urology Times. All rights reserved.
July 23, 2020
Treatment with litoxetine, an investigational oral selective serotonin reuptake inhibitor, led to nearly 22% of patients becoming continent.
July 22, 2020
Retreatment rates were low with both aquablation and transurethral resection of the prostate.
July 21, 2020
The EUPROMS patient-driven quality-of-life study included data from almost 3000 men treated for prostate cancer.
July 15, 2020
The phase 3 CONDOR study demonstrated excellent diagnostic performance with 18F-DCFPyL–PET/CT in men with biochemically relapsed prostate cancer, even at very low PSA values.